stoxline Quote Chart Rank Option Currency Glossary
  
Benitec Biopharma Inc. (BNTC)
3.22  -0.01 (-0.31%)    12-01 15:59
Open: 3.27
High: 3.425
Volume: 10,912
  
Pre. Close: 3.23
Low: 3.17
Market Cap: 8(M)
Technical analysis
2023-12-01 4:18:39 PM
Short term     
Mid term     
Targets 6-month :  4.21 1-year :  4.66
Resists First :  3.6 Second :  3.99
Pivot price 3.39
Supports First :  2.99 Second :  2.48
MAs MA(5) :  3.15 MA(20) :  3.47
MA(100) :  3.16 MA(250) :  3.54
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  20.9 D(3) :  12.3
RSI RSI(14): 47.1
52-week High :  9.01 Low :  1.86
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BNTC ] has closed above bottom band by 37.7%. Bollinger Bands are 3.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.47 - 3.49 3.49 - 3.5
Low: 3.02 - 3.04 3.04 - 3.06
Close: 3.15 - 3.18 3.18 - 3.21
Company Description

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.

Headline News

Thu, 30 Nov 2023
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a ... - BioSpace

Thu, 30 Nov 2023
Here's Why Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO ... - Yahoo Finance

Fri, 17 Nov 2023
2023-11-17 | NDAQ:BNTC | Press Release | Benitec Biopharma Inc - Stockhouse Publishing

Mon, 13 Nov 2023
Benitec Biopharma Releases First Quarter 2024 Financial Results ... - Yahoo Finance

Fri, 18 Aug 2023
JANUS HENDERSON GROUP PLC Acquires New Stake in Benitec ... - Yahoo Finance

Tue, 08 Aug 2023
Benitec Biopharma Inc. Announces Pricing of $30 Million ... - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 3 (M)
Held by Insiders 2e+006 (%)
Held by Institutions 0 (%)
Shares Short 68 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.026e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -27 %
Return on Assets (ttm) 166.6 %
Return on Equity (ttm) -56.4 %
Qtrly Rev. Growth 75000 %
Gross Profit (p.s.) 0
Sales Per Share -112.89
EBITDA (p.s.) 76530.6
Qtrly Earnings Growth -234.9 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -19 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.03
Price to Cash Flow 0.36
Stock Dividends
Dividend 0
Forward Dividend 46510
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android